US 11,678,986 B2
Device, system, and method for transcatheter treatment of valve regurgitation
Alexander Khairkhahan, Palo Alto, CA (US); and Michael D. Lesh, Mill Valley, CA (US)
Assigned to Polares Medical Inc., Palo Alto, CA (US)
Filed by Polares Medical Inc., Palo Alto, CA (US)
Filed on Jul. 21, 2022, as Appl. No. 17/870,274.
Application 17/870,274 is a continuation of application No. 16/717,363, filed on Dec. 17, 2019, granted, now 11,419,722.
Application 16/717,363 is a continuation of application No. 15/455,567, filed on Mar. 10, 2017, granted, now 10,512,542, issued on Dec. 24, 2019.
Application 15/455,567 is a continuation of application No. 14/542,091, filed on Nov. 14, 2014, granted, now 9,592,118, issued on Mar. 14, 2017.
Application 14/542,091 is a continuation of application No. 13/531,407, filed on Jun. 22, 2012, granted, now 8,888,843, issued on Nov. 18, 2014.
Application 13/531,407 is a continuation in part of application No. 13/099,532, filed on May 3, 2011, granted, now 8,845,717, issued on Sep. 30, 2014.
Claims priority of provisional application 61/437,397, filed on Jan. 28, 2011.
Prior Publication US 2022/0354648 A1, Nov. 10, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/24 (2006.01); A61B 17/04 (2006.01); A61L 27/04 (2006.01); A61L 27/36 (2006.01); A61L 27/06 (2006.01); A61L 27/50 (2006.01); A61B 17/068 (2006.01); A61B 17/064 (2006.01); A61B 90/00 (2016.01)
CPC A61F 2/2457 (2013.01) [A61B 17/0401 (2013.01); A61F 2/2418 (2013.01); A61F 2/2454 (2013.01); A61F 2/2466 (2013.01); A61L 27/042 (2013.01); A61L 27/06 (2013.01); A61L 27/3625 (2013.01); A61L 27/50 (2013.01); A61B 17/068 (2013.01); A61B 2017/0406 (2013.01); A61B 2017/0409 (2013.01); A61B 2017/0414 (2013.01); A61B 2017/0443 (2013.01); A61B 2017/0448 (2013.01); A61B 2017/0649 (2013.01); A61B 2090/08021 (2016.02); A61F 2210/0014 (2013.01); A61F 2220/0008 (2013.01); A61L 2400/16 (2013.01); A61L 2430/20 (2013.01)] 20 Claims
OG exemplary drawing
 
10. A coaptation implant system comprising:
a coaptation implant comprising:
a coaptation surface configured for an anterior leaflet of a valve to coapt against;
a superior edge, lateral edges, and an inferior edge, wherein a distance between the lateral edges generally decreases toward the inferior edge;
a hub; and
at least one strut extending from the hub; and
a helical anchor configured to be rotated relative to the hub,
wherein the coaptation implant is configured to experience some motion and deformation as surrounding cardiac structures move in relation to one another during the cardiac cycle.